Drug testing of biological specimens such as urine, oral fluid, sweat and hair provides an objective means of diagnosis of drug use and monitoring subjects while in treatment. Traditionally, urine testing has been used in the past, but this technology has limitations. In a series of ongoing studies, a variety of alternative biological fluids and tissues are being evaluated for their usefulness in monitoring individual patterns of substance abuse. Clinical studies were designed to determine the identity, concentration, time course, dose dependency and variability of drug and metabolite excretion in urine, plasma, saliva, sweat, skin, sebum, nails and hair following administration of single and multiple doses of drugs of abuse to human subjects. Each biological specimen appears to be unique and offers a somewhat different pattern of information regarding drug use over time. For example, hair testing offers the possibility of detecting drug use that could have occurred within a period of several months and could be useful in monitoring individuals in long-term treatment programs and in prevalence studies. In contrast, oral fluid testing is a short term measure of drug exposure that may correlate more closely with some drug concentrations in blood and with drug- induced effects. Oral fluid, hair and sweat testing for drugs of abuse are currently under consideration for federally mandated drug testing programs, and are being employed more commonly in workplace, criminal justice, treatment and military drug testing programs. Sweat testing can be used for drug monitoring over a period of 1-2 weeks. Each matrix may be useful for drug testing in different settings. However, there may also be disadvantages associated with the use of a particular biological matrix. The risk of false positives arising from environmental drug contamination is being evaluated along with the possibility of color bias in hair testing. Basic pharmacological properties such as dose-concentration and concentration-time relationships are evaluated in our research. Overall, each biological matrix shows promise of revealing useful information regarding an individual's drug exposure history. Analysis of drugs in alternative matrices requires development of sensitive, selective and specific chemical methods for the detection and quantitation of drugs and metabolites. Analytical procedures are continually evaluated for improving the detection and quantitation of parent drug and metabolic products of cocaine, opiates, methamphetamine, cannabinoids and nicotine in blood, plasma, sweat, oral fluid, urine, skin, sebum, meconium and hair.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Intramural Research (Z01)
Project #
1Z01DA000412-05
Application #
6680373
Study Section
(CPTR)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2002
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Scheidweiler, Karl B; Himes, Sarah K; Chen, Xiaohong et al. (2013) 11-Nor-9-carboxy-?9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 405:6019-27
Lee, Dayong; Karschner, Erin L; Milman, Garry et al. (2013) Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend 130:68-76
Castaneto, Marisol S; Barnes, Allan J; Scheidweiler, Karl B et al. (2013) Identifying methamphetamine exposure in children. Ther Drug Monit 35:823-30
Desrosiers, Nathalie A; Barnes, Allan J; Hartman, Rebecca L et al. (2013) Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration. Anal Bioanal Chem 405:4067-76
Scheidweiler, Karl B; Shakleya, Diaa M; Huestis, Marilyn A (2012) Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry. Clin Chim Acta 413:978-84
Lee, Dayong; Schwope, David M; Milman, Garry et al. (2012) Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem 58:748-56
Rahmim, Arman; Zhou, Yun; Tang, Jing et al. (2012) Direct 4D parametric imaging for linearized models of reversibly binding PET tracers using generalized AB-EM reconstruction. Phys Med Biol 57:733-55
Lu, Lijun; Karakatsanis, Nicolas A; Tang, Jing et al. (2012) 3.5D dynamic PET image reconstruction incorporating kinetics-based clusters. Phys Med Biol 57:5035-55
Milman, Garry; Schwope, David M; Schwilke, Eugene W et al. (2011) Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral ?(9)-tetrahydrocannabinol administration. Clin Chem 57:1597-606
Gray, Teresa R; Dams, Riet; Choo, Robin E et al. (2011) Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence. Forensic Sci Int 206:98-102

Showing the most recent 10 out of 51 publications